May 12, 2026
Cerevance
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
- Round
- Series C
- Amount raised
- $20M
- Lead investor
- Agent Capital
- Industry
- Biotechnology
- Headquarters
- Boston, United States
- Employees
- 51-100
- Website
- www.cerevance.com
- View profile →
Other investors
- Bioluminescence Ventures
- Dementia Discovery Fund
- Double Point Ventures
- Lightstone Ventures
- SV Health Investors
- Takeda
Source: Crunchbase snapshot 2026-05-15